ASH Clinical News | Page 54

Back of the Book Heard in the Blogosphere ASH @ASH_hematology Today ASH is one of the 300+ organizations urging #Congress to make funding for the @NIH a national priority. #RallyMedRes AACR Financial Toxicity of Cancer Drugs Several experts discussed the high cost of cancer drugs on a recent “60 Minutes” segment, including ASH member Hagop Kantarjian, MD, who co-authored a 2013 paper in Blood that criticized leukemia drug prices. “Here you have a drug that lets people live their normal life, but, in order to live normally, they are enslaved by the cost of the drug,” Dr. Kantarjian said. “[Pharmaceutical companies] are making prices unreasonable, unsustainable, and – in my opinion – immoral.” @AACR #RallyMedRes kickoff: People from across the country are urging Congress to increase #NIH funding. @60Minutes “The only drug that works is a drug that a patient can afford.” @60Minutes The “eye-popping” cost of cancer drugs. ASH @ASH_hematology Meet the 2014 ASH Advocacy Leadership Institute Participants! Top Scientists Suggest A Few Fixes for Medical Funding Crisis There’s no do V'BF